ABCG2 and breast carcinoma: Our results showed that no significant association between ABCG2 C421A polymorphisms and clinicopathological features (age at diagnosis, menopausal state, age at menarche histology, clinical stage, lymph node metastasis, Ki67 status, ER status, PR status, HER2 status) of breast cancer patients.